Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
559.17
459.95
661.23
624.81
544.06
456.70
596.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
559.17
459.95
661.23
624.81
544.06
456.70
596.16
Raw Material Cost
210.46
211.03
281.25
168.48
179.30
125.87
179.63
Purchase of Finished goods
1.80
7.26
29.92
11.69
10.71
9.19
18.35
(Increase) / Decrease In Stocks
17.86
34.37
-48.97
24.46
-33.22
37.18
-10.73
Employee Cost
149.57
126.48
182.94
156.17
142.32
147.08
151.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
167.82
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
199.54
178.77
229.95
187.37
213.59
268.57
3.37
Total Expenditure (Excl Depreciation)
579.23
557.91
675.09
548.17
512.70
587.89
510.03
Operating Profit (PBDIT) excl Other Income
-20.06
-97.96
-13.86
76.64
31.36
-131.19
86.13
Other Income
25.80
51.66
10.97
9.98
29.69
4.48
7.78
Operating Profit (PBDIT)
5.74
-46.30
-2.89
86.62
61.05
-126.71
93.91
Interest
3.58
4.44
180.84
185.34
173.98
104.83
100.58
Exceptional Items
36.03
102.66
1,676.21
0.00
-15.40
334.01
0.00
Gross Profit (PBDT)
38.19
51.92
1,492.48
-98.72
-128.33
102.47
-6.67
Depreciation
36.71
39.12
43.66
45.60
43.22
54.00
57.28
Profit Before Tax
1.48
12.80
1,448.82
-144.32
-171.55
48.47
-63.95
Tax
2.98
46.55
370.91
1.96
16.64
7.71
9.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.50
-33.75
1,077.91
-146.28
-188.19
40.76
-73.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
-1.45
-6.43
-3.24
0.00
Net Profit
-1.50
-33.75
1,077.91
-147.73
-194.62
37.52
-76.21
Share in Profit of Associates
0.00
0.00
0.00
0.08
0.33
0.15
0.21
Minority Interest
0.33
0.00
-0.02
0.00
0.00
0.00
-2.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1.17
-33.75
1,077.89
-147.65
-194.29
37.67
-78.02
Equity Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
835.92
837.48
842.67
-234.82
192.66
0.00
0.00
Earnings per share (EPS)
-0.19
-5.51
175.84
-24.09
-31.69
6.15
-12.73
Diluted Earnings per share
-0.19
-5.43
175.98
-24.11
-31.72
6.15
-12.41
Operating Profit Margin (Excl OI)
-3.59%
-21.3%
-2.1%
12.27%
5.76%
-28.73%
14.45%
Gross Profit Margin
6.83%
11.29%
225.71%
-15.8%
-23.59%
22.44%
-1.12%
PAT Margin
-0.27%
-7.34%
163.02%
-23.4%
-34.53%
8.96%
-12.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 21.57% vs -30.44% in Mar 2023
Consolidate Net Profit
YoY Growth in year ended Mar 2024 is 96.53% vs -103.13% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 79.52% vs -606.78% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is -19.37% vs -97.54% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Panacea Biotec With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
559.17
10,334.77
-9,775.60
-94.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
559.17
10,334.77
-9,775.60
-94.59%
Raw Material Cost
210.46
1,853.52
-1,643.06
-88.65%
Purchase of Finished goods
1.80
1,409.85
-1,408.05
-99.87%
(Increase) / Decrease In Stocks
17.86
-53.67
71.53
133.28%
Employee Cost
149.57
2,274.73
-2,125.16
-93.42%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
199.54
2,315.28
-2,115.74
-91.38%
Total Expenditure (Excl Depreciation)
579.23
7,799.71
-7,220.48
-92.57%
Operating Profit (PBDIT) excl Other Income
-20.06
2,535.06
-2,555.12
-100.79%
Other Income
25.80
280.86
-255.06
-90.81%
Operating Profit (PBDIT)
5.74
2,815.92
-2,810.18
-99.80%
Interest
3.58
33.53
-29.95
-89.32%
Exceptional Items
36.03
0.00
36.03
Gross Profit (PBDT)
38.19
2,782.39
-2,744.20
-98.63%
Depreciation
36.71
398.25
-361.54
-90.78%
Profit Before Tax
1.48
2,384.14
-2,382.66
-99.94%
Tax
2.98
457.58
-454.60
-99.35%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-1.50
1,926.56
-1,928.06
-100.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-1.50
1,926.56
-1,928.06
-100.08%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.33
-28.87
29.20
101.14%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1.17
1,912.90
-1,914.07
-100.06%
Equity Capital
6.13
40.06
-33.93
-84.70%
Face Value
1.00
1.00
0.00
Reserves
835.92
9,323.03
-8,487.11
-91.03%
Earnings per share (EPS)
-0.19
47.75
-47.94
-100.40%
Diluted Earnings per share
-0.19
47.68
-47.87
-100.40%
Operating Profit Margin (Excl OI)
-3.59%
24.53%
0.00
-28.12%
Gross Profit Margin
6.83%
26.92%
0.00
-20.09%
PAT Margin
-0.27%
18.79%
0.00
-19.06%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 559.17 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 21.57% vs -30.44% in Mar 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -1.17 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 96.53% vs -103.13% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -20.06 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 79.52% vs -606.78% in Mar 2023
Annual - Interest
Interest 3.58 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -19.37% vs -97.54% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -3.59%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
